Letters
Views

Arq. Bras. Oftalmol. 2023; 86 (4):

Total: 2998

Dexamethasone intravitreal implant as an adjuvant treatment for pediatric patients with Coats’ disease

Submission is temporarily unavailable. reCAPTCHA validation has not been configured yet.
This article not yet has been commented, be the first!

PDF English Print
Open Access
Share

How to cite this article:

Implante intravítreo de dexametasona como tratamento adjuvante em pacientes pediátricos com doença de Coats. Arq. Bras. Oftalmol. 2023;86(4):.
Export citation